(S)-3-(tert-Butyl-dimethyl-silanyloxy)-pent-4-enoic acid methyl ester | 159911-14-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (S)-3-(tert-Butyl-dimethyl-silanyloxy)-pent-4-enoic acid methyl ester
• 英文别名: methyl (3S)-3-[tert-butyl(dimethyl)silyl]oxypent-4-enoate
• CAS: 159911-14-5
• 化学式: C₁₂H₂₄O₃Si
• 分子量: 244.406
• InChiKey: YQBULPOBXBWJNB-SNVBAGLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.13
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-3-(tert-Butyl-dimethyl-silanyloxy)-pent-4-enoic acid methyl ester 在 二(3-甲基丁烷-2-基)硼烷 、 pyridinium chlorochromate 作用下， 生成 (3R)-(-)-methyl 3-<(tert-butyldimethylsilyl)oxy>-4-formylbutanoate
  参考文献：
  名称：

  Synthesis of Intermediates for the Lactone Moiety of Mevinic Acids via Tellurium Chemistry

  摘要：

  Treatment of p-toluenesulfonates of epoxides of specific primary allylic alcohols with telluride ion, prepared in situ by reduction of relatively nontoxic elemental tellurium, installs the two key secondary alcohol functions that occur in the lactone part of the cholesterol-lowering drugs, compactin, mevinolin, and lovastatin. Since the epoxides of the primary allylic alcohol starting materials can be synthesized in optically active form by the Sharpless-Katsuki asymmetric epoxidation (SAE) process, the stereospecific telluride transposition can give optically active secondary allylic alcohols configured for maximum inhibition of cholesterol function.

  DOI：

  10.1021/jo00096a017
• 作为产物：
  描述：

  3-hydroxypent-4-enoic acid methyl ester 、 叔丁基二甲基氯硅烷 在 咪唑 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (S)-3-(tert-Butyl-dimethyl-silanyloxy)-pent-4-enoic acid methyl ester
  参考文献：
  名称：

  Synthesis of Intermediates for the Lactone Moiety of Mevinic Acids via Tellurium Chemistry

  摘要：

  Treatment of p-toluenesulfonates of epoxides of specific primary allylic alcohols with telluride ion, prepared in situ by reduction of relatively nontoxic elemental tellurium, installs the two key secondary alcohol functions that occur in the lactone part of the cholesterol-lowering drugs, compactin, mevinolin, and lovastatin. Since the epoxides of the primary allylic alcohol starting materials can be synthesized in optically active form by the Sharpless-Katsuki asymmetric epoxidation (SAE) process, the stereospecific telluride transposition can give optically active secondary allylic alcohols configured for maximum inhibition of cholesterol function.

  DOI：

  10.1021/jo00096a017

文献信息

• Kumar Archana, Dittmer Donald C., J. Org. Chem, 59 (1994) N 17, S 4760-4764
  作者：Kumar Archana, Dittmer Donald C.

  DOI：——

  日期：——
• Synthesis of Intermediates for the Lactone Moiety of Mevinic Acids via Tellurium Chemistry
  作者：Archana Kumar、Donald C. Dittmer

  DOI：10.1021/jo00096a017

  日期：1994.8

  Treatment of p-toluenesulfonates of epoxides of specific primary allylic alcohols with telluride ion, prepared in situ by reduction of relatively nontoxic elemental tellurium, installs the two key secondary alcohol functions that occur in the lactone part of the cholesterol-lowering drugs, compactin, mevinolin, and lovastatin. Since the epoxides of the primary allylic alcohol starting materials can be synthesized in optically active form by the Sharpless-Katsuki asymmetric epoxidation (SAE) process, the stereospecific telluride transposition can give optically active secondary allylic alcohols configured for maximum inhibition of cholesterol function.